SCHEMBL17099285

SCHEMBL17099285

CCOC(=O)[C@H]1CC[C@H](n2ncc(C(=O)N(Cc3cc(F)cc(F)c3)CC(O)c3c(OC)cccc3OC)c2C(F)(F)F)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.35
NR1H4 Q96RI1 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
CCR2 P41597 1/20 0.33
KCNH2 Q12809 1/20 0.33
NTRK1 P04629 1/20 0.33
ALDH1A1 P00352 6/20 0.33
KDM4E B2RXH2 5/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
HPGD P15428 2/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 2/20 0.32
THRB P10828 1/20 0.32
ATM Q13315 1/20 0.32
LPAR1 Q92633 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17099286 1.00 EGFR (0.35) EGFRNR1H4L3MBTL1CCR2KCNH2
SCHEMBL17098281 0.97 POLB (0.34) EGFRNR1H4L3MBTL1KDM4EKMT2A
SCHEMBL17098282 0.97 POLB (0.34) EGFRNR1H4L3MBTL1KDM4EKMT2A
SCHEMBL17117925 0.97 ALDH1A1 (0.35) EGFRNR1H4L3MBTL1CCR2KCNH2
SCHEMBL17117924 0.92 NR1H4 (0.34) NR1H4L3MBTL1CCR2KCNH2NTRK1
SCHEMBL17098472 0.92 EGFR (0.34) EGFRNR1H4L3MBTL1CCR2KCNH2
SCHEMBL17098475 0.92 EGFR (0.34) EGFRNR1H4L3MBTL1CCR2KCNH2
SCHEMBL17048962 0.92 ALDH1A1 (0.34) EGFRALDH1A1KDM4EKMT2AMAPT
SCHEMBL17099186 0.88 EGFR (0.36) EGFRNR1H4L3MBTL1CCR2KCNH2
SCHEMBL17099185 0.88 EGFR (0.36) EGFRNR1H4L3MBTL1CCR2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA EGFR 4069/4885NR1H4 26/4885L3MBTL1 4342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.